Attached files
| file | filename |
|---|---|
| EX-10.1 - EX-10.1 - NEEDHAM EMPLOYMENT AGREEMENT - MERRIMACK PHARMACEUTICALS INC | mack-ex101_380.htm |
| EX-10.2 - EX-10.2 - FRANCHI EMPLOYMENT AGREEMENT - MERRIMACK PHARMACEUTICALS INC | mack-ex102_379.htm |
| EX-31.2 - EX-31.2 - MERRIMACK PHARMACEUTICALS INC | mack-ex312_7.htm |
| 10-Q - 10-Q - MERRIMACK PHARMACEUTICALS INC | mack-10q_20170930.htm |
| EX-32.2 - EX-32.2 - MERRIMACK PHARMACEUTICALS INC | mack-ex322_10.htm |
| EX-31.1 - EX-31.1 - MERRIMACK PHARMACEUTICALS INC | mack-ex311_8.htm |
| EX-3.1 - EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED - MERRIMACK PHARMACEUTICALS INC | mack-ex31_381.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Merrimack Pharmaceuticals, Inc. (the “Company”) for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Richard Peters, M.D., Ph.D., President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: November 8, 2017 |
|
/s/ Richard Peters, M.D., Ph.D. |
|
|
|
Richard Peters, M.D., Ph.D. |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |